 The primary outcomes of interest in Lung VITAL are COPDasthma exacerbations and dyspnea shortness of breath; airflow obstruction and decline of pulmonary function; and pneumonia. Asthma control is a secondary outcome; and new-onset COPD and asthma are tertiary outcomes. 